By proceeding, you agree to our Terms of Use and Privacy Policy.
Oligonucleotide Therapeutics - the emerging medicine class - are harnessing the therapeutic benefit of targeting genetic material utilising oligonucleotide conjugates, antisense oligonucleotides (ASOs), mRNA and RNAi.
Explore insights on the regulatory and CMC environment surrounding oligonucleotide therapeutic development.
Discover the latest innovations in oligonucleotide therapeutics like AI machine learning to drive the discovery of novel therapeutics.
Learn from and engage with experts like Bart Anderson, Dmitry Samarsky, Heinrich Haas, Macarena Hernandez- Jimenez, Matthew Wood, Oliver Ernst and others.
SAE Media Group Conferences, based in London, connects global communities with focused networking conferences.
Catalent is a global leader in providing integrated services, superior delivery technologies, and manufacturing solutions to help life science innovators develop and launch successful pharmaceuticals, biologics, and consumer health products
All trademarks, registered trademarks, product names, and company names or logos mentioned in or on this site are the property of their respective owners.
A great community. Legit content. The kind of emails you actually look forward to.